Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Block listing Interim Review

3 Jan 2017 07:00

RNS Number : 1261T
Ubisense Group PLC
03 January 2017
 

Name of company:

Ubisense Group Plc

Name of scheme:

Ubisense Group Plc 2006 Employers' Share Option Scheme, Unapproved Options Agreement and US Incentive Stock Option Agreement

Period of return:

From:

01/07/2016

To:

31/12/2016

Number and class of securities originally admitted and the date of admission:

21,421,758 ordinary shares of £0.02 each on 22 June 2011

Balance of unallotted securities under scheme(s) from previous return:

157,349

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

157,349

BLOCK LISTING SIX MONTHLY RETURN

 

 

 

 

 

Name of contact:

Tim Gingell

 

Telephone number of contact:

+44 1223 535 170

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRDBGDBRGGBGRD

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.